- Home
- WRAP vs PSNL Comparison
WRAP vs PSNL Comparison
Compare WRAP & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WRAP
- PSNL
- Stock Information
- Founded
- WRAP 2016
- PSNL 2011
- Country
- WRAP United States
- PSNL United States
- Employees
- WRAP N/A
- PSNL N/A
- Industry
- WRAP Ordnance And Accessories
- PSNL Medical Specialities
- Sector
- WRAP Industrials
- PSNL Health Care
- Exchange
- WRAP Nasdaq
- PSNL Nasdaq
- Market Cap
- WRAP 68.8M
- PSNL 321.1M
- IPO Year
- WRAP N/A
- PSNL 2019
- Fundamental
- Price
- WRAP $1.70
- PSNL $5.19
- Analyst Decision
- WRAP
- PSNL Strong Buy
- Analyst Count
- WRAP 0
- PSNL 4
- Target Price
- WRAP N/A
- PSNL $6.81
- AVG Volume (30 Days)
- WRAP 191.1K
- PSNL 439.4K
- Earning Date
- WRAP 10-15-2024
- PSNL 11-06-2024
- Dividend Yield
- WRAP N/A
- PSNL N/A
- EPS Growth
- WRAP N/A
- PSNL N/A
- EPS
- WRAP N/A
- PSNL N/A
- Revenue
- WRAP $7,269,000.00
- PSNL $80,027,000.00
- Revenue This Year
- WRAP N/A
- PSNL $10.85
- Revenue Next Year
- WRAP N/A
- PSNL $8.77
- P/E Ratio
- WRAP N/A
- PSNL N/A
- Revenue Growth
- WRAP 0.99
- PSNL 19.20
- 52 Week Low
- WRAP $1.21
- PSNL $0.89
- 52 Week High
- WRAP $7.01
- PSNL $7.20
- Technical
- Relative Strength Index (RSI)
- WRAP 56.79
- PSNL 56.29
- Support Level
- WRAP $1.71
- PSNL $4.54
- Resistance Level
- WRAP $1.93
- PSNL $5.35
- Average True Range (ATR)
- WRAP 0.16
- PSNL 0.30
- MACD
- WRAP 0.01
- PSNL 0.05
- Stochastic Oscillator
- WRAP 61.70
- PSNL 84.71
About WRAP Wrap Technologies Inc.
Wrap Technologies Inc offers public safety technologies and services. The firm develops policing solutions to law enforcement and security personnel. Its BolaWRAP 150 Remote Restraint device is a patented, hand-held tool that discharges a Kevlar cord to restrain noncompliant individuals from a range of 10-25 feet. The group operates in the Americas, Europe, the Middle East, Africa and the Asia Pacific.
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.